Skip to content

Effect of 5 herbs powder on blood glucose levels in Type 1 diabetic children.

Impact of combo herbal supplement intervention on hypoglycemic effect in Type 1 diabetic children: A randomized controlled trial.

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/12/016696
Enrollment
60
Registered
2018-12-17
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E109- Type 1 diabetes mellitus without complications

Interventions

Intervention1: herbal supplements of following herbs will be used for intervention.: Gymnema sylvestre-50gm Momordica charantia-25gm Azadiracta indica-50gm Citrullus colocynthis-50gm Berberis aristata

Sponsors

Sukhjindar Singh Ghotra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Aged between 4- 14 years. Diabetic Children with Type 1 Diabetes. Physician approval for selected patient. Parentâ??s willingness to provide informed consent. Diabetes diagnosed for at least 6 months.

Exclusion criteria

Exclusion criteria: Any preexisting condition / contraindications (abnormal creatinine levels, liver dysfunction). Patients due for operations. Enrolled in other active intervention research studies.

Design outcomes

Primary

MeasureTime frame
Anthropometric factors - Weight management (weight increase in case of underweight) - BMI (Improvement) 2. Biochemical factorsImprovement - FBG - PPBG - HbA1c - C-peptide Decreased requirement of Insulin /unit / kg bodyweight 5. decrease in Hypoglycemic eventsTimepoint: 6 months

Secondary

MeasureTime frame
Improvement in general health of diabetic patientsTimepoint: six months

Countries

India

Contacts

Public ContactSukhjindar Singh Ghotra

Postgraduate Institute of Medical Education and Research

sukhji05@gmail.com9467677012

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026